Association of a Lay Health Worker Intervention With Symptom Burden, Survival, Health Care Use, and Total Costs Among Medicare Enrollees With Cancer.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 03 2020
Historique:
entrez: 17 3 2020
pubmed: 17 3 2020
medline: 9 9 2020
Statut: epublish

Résumé

Undertreated patient symptoms require approaches that improve symptom burden. To determine the association of a lay health worker-led symptom screening and referral intervention with symptom burden, survival, health care use, and total costs among Medicare Advantage enrollees with a new diagnosis of solid or hematologic malignant neoplasms. This quality improvement study conducted at 9 community oncology practices from November 1, 2016, to October 31, 2018, compared newly diagnosed Medicare Advantage enrollees with solid or hematologic malignant neoplasms with patients diagnosed and treated 1 year prior. Analysis was conducted from August 1, 2019, to January 11, 2020. Usual care augmented by a lay health worker trained to screen symptoms and refer patients to palliative care and behavioral medicine. The primary outcome was change in symptoms using the Edmonton Symptom Assessment Scale and the 9-item Patient Health Questionnaire at baseline and 6 and 12 months after enrollment. Secondary outcomes were between-group comparison of survival, 12-month health care use, and costs. Among 425 patients in the intervention group and 407 patients in the control group, the mean (SD) age was 78.8 (8.3) years, 345 (41.5%) were female, and 407 (48.9%) were non-Hispanic white. Patients in the intervention group experienced a lower symptom burden as measured by the Edmonton Symptom Assessment Scale score over time compared with patients in the control group (mean [SD] difference, -1.9 [14.2]; 95% CI, -3.77 to -0.19; P = .01 for the intervention group and 2.32 [17.7]; 95% CI, 0.47 to 4.19; P = .02 for the control group). Similar findings were noted in 9-item Patient Health Questionnaire depression scores (mean [SD] difference, -0.63 [3.99]; 95% CI, -1.23 to -0.028; P = .04 for the intervention group and 1.67 [5.49]; 95% CI, 0.95 to 2.37; P = .01 for the control group). Patients in the intervention group compared with patients in the control group had fewer mean (SD) inpatient visits (0.54 [0.77]; 95% CI, 0.47-0.61 vs 0.72 [1.12]; 95% CI, 0.61-0.83; P = .04) and emergency department visits (0.43 [0.76]; 95% CI, 0.36-0.50 vs 0.57 [1.00]; 95% CI, 0.48-0.67; P = .002) per 1000 patients per year and lower total costs (median, $17 869 [interquartile range, $6865-$32 540] vs median, $18 473 [interquartile range, $6415-$37 910]; P = .02). A total of 180 patients in the intervention group and 189 patients in the control group died within 12 months. Among those who died, patients in the intervention group had greater hospice use (125 of 180 [69.4%] vs 79 of 189 [41.8%]; odds ratio, 3.16; 95% CI, 2.13-4.69; P < .001), fewer mean (SD) emergency department and hospital visits (emergency department: 0.10 [0.30]; 95% CI, 0.06-0.14 vs 0.30 [0.46]; 95% CI, 0.24-0.38; P = .001; hospital: 0.27 [0.44]; 95% CI, 0.21-0.34 vs 0.43 [0.82]; 95% CI, 0.32-0.55; P = .02), and lower costs (median, $3602 [interquartile range, $1076-$9436] vs median, $12 726 [interquartile range, $5259-$22 170]; P = .002), but there was no significant difference in inpatient deaths (18 of 180 [10.0%] vs 30 of 189 [15.9%]; P = .14). This study suggests that a lay health worker-led intervention may be one way to improve burdensome and costly care.

Identifiants

pubmed: 32176306
pii: 2762791
doi: 10.1001/jamanetworkopen.2020.1023
pmc: PMC7076340
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e201023

Subventions

Organisme : NIMHD NIH HHS
ID : K23 MD013474
Pays : United States

Références

Am J Hosp Palliat Care. 2019 Dec;36(12):1081-1088
pubmed: 31046401
J Oncol Pract. 2015 Jan;11(1):e98-e102
pubmed: 25271246
J Oncol Pract. 2019 Jan;15(1):e46-e55
pubmed: 30444666
J Pain Symptom Manage. 2014 Jun;47(6):973-89
pubmed: 24210705
J Oncol Pract. 2017 Apr;13(4):e291-e302
pubmed: 28399387
Breast Cancer Res Treat. 2018 Jan;167(1):215-223
pubmed: 28900752
JAMA. 2017 Nov 21;318(19):1935-1936
pubmed: 29164251
J Pain Symptom Manage. 2002 Nov;24(5):526-42
pubmed: 12547052
J Clin Oncol. 2014 Dec 20;32(36):4149-54
pubmed: 25403222
Cancer. 2017 Dec 1;123(23):4720-4727
pubmed: 29057450
JAMA. 2016 Aug 2;316(5):538-40
pubmed: 27483069
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Ann Oncol. 2008 Dec;19(12):1985-91
pubmed: 18632721
Cancer. 2019 Nov 15;125(22):4059-4068
pubmed: 31373682
BMJ Qual Saf. 2016 Dec;25(12):986-992
pubmed: 26369893
Ann Oncol. 2017 Sep 1;28(9):2305-2311
pubmed: 28911065
J Pain Symptom Manage. 2016 Jun;51(6):1070-1090.e9
pubmed: 27112310
Am J Hosp Palliat Care. 2018 Mar;35(3):497-504
pubmed: 28691498
Health Aff (Millwood). 2017 Jul 1;36(7):1211-1217
pubmed: 28679807
JAMA Oncol. 2017 Jun 1;3(6):817-825
pubmed: 28125760
Ann Oncol. 2016 Feb;27(2):324-32
pubmed: 26646758
J Oncol Pract. 2019 Feb;15(2):e91-e97
pubmed: 30576262
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
Support Care Cancer. 2013 Jun;21(6):1525-50
pubmed: 23314601
J Palliat Med. 2015 Jun;18(6):542-4
pubmed: 25789759
J Palliat Care. 1991 Summer;7(2):6-9
pubmed: 1714502
J Oncol Pract. 2015 Jul;11(4):280-4
pubmed: 25991638
JAMA. 2017 Jul 11;318(2):197-198
pubmed: 28586821
JAMA Oncol. 2018 Oct 1;4(10):1359-1366
pubmed: 30054634
Gen Hosp Psychiatry. 2009 May-Jun;31(3):240-53
pubmed: 19410103
BMC Med Res Methodol. 2014 Feb 10;14:20
pubmed: 24512175
JCO Oncol Pract. 2020 Jan;16(1):e19-e28
pubmed: 31550213

Auteurs

Manali I Patel (MI)

Division of Oncology, Stanford University School of Medicine, Stanford, California.
Medical Services, Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
Center for Primary Care and Outcomes Research/Health Research and Policy, Stanford University School of Medicine, Stanford, California.

David Ramirez (D)

CareMore Health, Cerritos, California.

Richy Agajanian (R)

The Oncology Institute of Hope and Innovation, Downy, California.

Hilda Agajanian (H)

The Oncology Institute of Hope and Innovation, Downy, California.

Tumaini Coker (T)

Seattle Children's Research Institute, Seattle, Washington.
Department of Pediatrics, University of Washington School of Medicine, Seattle.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH